Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension ; day:07 ; month:08 ; year:2021 ; extent:15
Advanced science ; (07.08.2021) (gesamt 15)
- Creator
-
Jin, Seung Mo
Lee, Sang Nam
Kim, Jung Eun
Yoo, Yeon Jeong
Song, Chanyoung
Shin, Hong Sik
Phuengkham, Hathaichanok
Lee, Chang Hoon
Um, Soong Ho
Lim, Yong Taik
- DOI
-
10.1002/advs.202102043
- URN
-
urn:nbn:de:101:1-2021080715245689401505
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jin, Seung Mo
- Lee, Sang Nam
- Kim, Jung Eun
- Yoo, Yeon Jeong
- Song, Chanyoung
- Shin, Hong Sik
- Phuengkham, Hathaichanok
- Lee, Chang Hoon
- Um, Soong Ho
- Lim, Yong Taik
Other Objects (12)
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
Understanding and overcoming the immunosuppressive effects of glioma induced immunosuppression
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
CaCO3-Assisted Preparation of pH-Responsive Immune-Modulating Nanoparticles for Augmented Chemo-Immunotherapy
Immunosuppression
Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist
Specifically blocking αvβ8-mediated TGF-β signaling to reverse immunosuppression by modulating macrophage polarization
Chemical immunosuppression
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression
Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells
Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy
Immunosuppression by cytostatic drugs?
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
Understanding and overcoming the immunosuppressive effects of glioma induced immunosuppression
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
CaCO3-Assisted Preparation of pH-Responsive Immune-Modulating Nanoparticles for Augmented Chemo-Immunotherapy
Immunosuppression
Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist
Specifically blocking αvβ8-mediated TGF-β signaling to reverse immunosuppression by modulating macrophage polarization
Chemical immunosuppression
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression
Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells
Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy
Immunosuppression by cytostatic drugs?
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
Understanding and overcoming the immunosuppressive effects of glioma induced immunosuppression
Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody
CaCO3-Assisted Preparation of pH-Responsive Immune-Modulating Nanoparticles for Augmented Chemo-Immunotherapy
Immunosuppression
Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist
Specifically blocking αvβ8-mediated TGF-β signaling to reverse immunosuppression by modulating macrophage polarization
Chemical immunosuppression
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression
Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells
Hyaluronic acid-bilirubin nanomedicine-based combination chemoimmunotherapy